GlassScriptPhysician profile
Michael J Grille
NPI 1659630960
$10,101.76
in general payments reported to CMS, 2019-2025
46 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,580 · 2020: $1,007 · 2021: $1,108 · 2022: $1,805 · 2023: $1,455 · 2024: $1,129 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,600.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,364.95 | 2019-2025 | General - Pain Management |
| Abbott Laboratories | $1,581.16 | 2019-2024 | Proclaim |
| Spr Therapeutics, INC | $493.65 | 2021-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $406.04 | 2019-2025 | Ztlido |
| Vertos Medical, INC. | $327.07 | 2021-2024 | Mild Device Kit |
| Medtronic, INC. | $324.00 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Curonix LLC | $240.54 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $224.36 | 2019-2022 | |
| Bioventus LLC | $196.83 | 2019-2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $188.62 | 2023-2024 | Iovera, Zilretta |
| Abbvie INC. | $187.71 | 2021-2025 | |
| Tersera Therapeutics LLC | $181.24 | 2023-2024 | Prialt |
| Daiichi Sankyo INC. | $177.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.85 | 2019-2025 | Relistor |
| Nevro Corp. | $162.16 | 2024 | Senza |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.